Bacillus clausii
- Generic Name
- Bacillus clausii
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- KQ2N4RPK58
- Associated Conditions
- Abdominal Pain, Abnormal Intestinal Absorption, Diarrhea, Flatulence, Intestinal Bacteria Flora Disturbance
- Associated Therapies
- -
Comparison of Effectiveness of Zinc Supplementation With ORS and Bacillus Clausii Versus Zinc With ORS and Saccharomyces Boulardii in Acute Watery Diarrhea in Paediatric Patients
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- RESnTEC, Institute of Research
- Target Recruit Count
- 60
- Registration Number
- NCT06540209
- Locations
- 🇵🇰
University of Child Health Sciences, The Children's Hospital, Lahore, Punjab, Pakistan
Impact of Bacillus Clausii Administration on Irritable Bowel Syndrome Patients
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-12-02
- Last Posted Date
- 2018-03-13
- Lead Sponsor
- Hospital Britanico
- Target Recruit Count
- 80
- Registration Number
- NCT03359499
- Locations
- 🇦🇷
Hospital Britanico, Buenos Aires, Caba, Argentina
Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American Children
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-06-23
- Last Posted Date
- 2016-01-21
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 629
- Registration Number
- NCT02169817
- Locations
- 🇧🇷
076003, Salvador, Brazil
🇦🇷06, San Miguel de Tucuman, Argentina
🇧🇷076002, Curitiba, Brazil
ENterogermina® (Bacillus Clausii) In the manaGeMent of diarrheA in Children
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-04-06
- Last Posted Date
- 2009-01-21
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 264
- Registration Number
- NCT00457353
- Locations
- 🇮🇳
Sanofi-Aventis, Mumbai, India
DIAMANTE - Diseases Infectious Analysis Microflora Antibiotic Effect
- First Posted Date
- 2007-01-22
- Last Posted Date
- 2008-12-01
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 60
- Registration Number
- NCT00424905
- Locations
- 🇮🇹
Sanofi-Aventis, Milan, Italy
EFESO - EFficacy Enterogermina Small Intestinal Bacterial Overgrowth
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-05-31
- Last Posted Date
- 2009-07-20
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 250
- Registration Number
- NCT00331994
- Locations
- 🇮🇹
Sanofi-Aventis Administrative Office, Milan, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath